Jazz Pharmaceuticals Future Growth
Future criteria checks 3/6
Jazz Pharmaceuticals is forecast to grow earnings and revenue by 17.3% and 5.8% per annum respectively. EPS is expected to grow by 16% per annum. Return on equity is forecast to be 22.1% in 3 years.
Key information
17.3%
Earnings growth rate
16.0%
EPS growth rate
Pharmaceuticals earnings growth | 19.5% |
Revenue growth rate | 5.8% |
Future return on equity | 22.1% |
Analyst coverage | Good |
Last updated | 13 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,583 | 731 | 1,654 | 1,489 | 16 |
12/31/2025 | 4,393 | 652 | 1,477 | 1,403 | 20 |
12/31/2024 | 4,098 | 479 | 1,299 | 1,157 | 20 |
12/31/2023 | 3,834 | 415 | 1,049 | 1,092 | N/A |
9/30/2023 | 3,794 | 80 | 867 | 1,267 | N/A |
6/30/2023 | 3,763 | -87 | 987 | 1,377 | N/A |
3/31/2023 | 3,738 | -156 | 918 | 1,384 | N/A |
12/31/2022 | 3,659 | -224 | 774 | 1,272 | N/A |
9/30/2022 | 3,584 | -19 | 984 | 1,108 | N/A |
6/30/2022 | 3,481 | -52 | 809 | 964 | N/A |
3/31/2022 | 3,300 | -450 | 622 | 702 | N/A |
12/31/2021 | 3,094 | -330 | 733 | 779 | N/A |
9/30/2021 | 2,863 | -161 | 711 | 787 | N/A |
6/30/2021 | 2,626 | 40 | 708 | 771 | N/A |
3/31/2021 | 2,436 | 518 | 750 | 912 | N/A |
12/31/2020 | 2,364 | 239 | 520 | 900 | N/A |
9/30/2020 | 2,280 | 179 | 455 | 801 | N/A |
6/30/2020 | 2,217 | 133 | 478 | 881 | N/A |
3/31/2020 | 2,188 | 280 | 509 | 847 | N/A |
12/31/2019 | 2,162 | 523 | 594 | 776 | N/A |
9/30/2019 | 2,056 | 609 | 726 | 907 | N/A |
6/30/2019 | 1,988 | 656 | 676 | 791 | N/A |
3/31/2019 | 1,954 | 486 | 646 | 834 | N/A |
12/31/2018 | 1,891 | 447 | 667 | 799 | N/A |
9/30/2018 | 1,851 | 520 | 642 | 785 | N/A |
6/30/2018 | 1,793 | 434 | 530 | 753 | N/A |
3/31/2018 | 1,687 | 447 | 578 | 696 | N/A |
12/31/2017 | 1,619 | 488 | 579 | 693 | N/A |
9/30/2017 | 1,579 | 372 | N/A | 669 | N/A |
6/30/2017 | 1,541 | 399 | N/A | 613 | N/A |
3/31/2017 | 1,528 | 408 | N/A | 605 | N/A |
12/31/2016 | 1,488 | 397 | N/A | 592 | N/A |
9/30/2016 | 1,432 | 363 | N/A | 531 | N/A |
6/30/2016 | 1,399 | 361 | N/A | 573 | N/A |
3/31/2016 | 1,352 | 335 | N/A | 587 | N/A |
12/31/2015 | 1,325 | 330 | N/A | 532 | N/A |
9/30/2015 | 1,312 | 328 | N/A | 545 | N/A |
6/30/2015 | 1,278 | 266 | N/A | 499 | N/A |
3/31/2015 | 1,235 | 222 | N/A | 434 | N/A |
12/31/2014 | 1,173 | 58 | N/A | 408 | N/A |
9/30/2014 | 1,081 | 32 | N/A | 353 | N/A |
6/30/2014 | 1,006 | 82 | N/A | 354 | N/A |
3/31/2014 | 923 | 80 | N/A | 287 | N/A |
12/31/2013 | 872 | 216 | N/A | 288 | N/A |
9/30/2013 | 820 | 327 | N/A | 314 | N/A |
6/30/2013 | 764 | 285 | N/A | 227 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: JAZZ N's forecast earnings growth (17.3% per year) is above the savings rate (7.7%).
Earnings vs Market: JAZZ N's earnings (17.3% per year) are forecast to grow faster than the MX market (9.8% per year).
High Growth Earnings: JAZZ N's earnings are forecast to grow, but not significantly.
Revenue vs Market: JAZZ N's revenue (5.8% per year) is forecast to grow slower than the MX market (6.9% per year).
High Growth Revenue: JAZZ N's revenue (5.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: JAZZ N's Return on Equity is forecast to be high in 3 years time (22.1%)